Stock Chart

AMRX

$20.19 +0.57%
Score: 37.8 AVOID NEW MONEY
LEAPs: SELL $13
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $13
Premium: $1.45
Expiry: Jun 18, 2026
Target: $12
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.49x (vs SPY: 0.7x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About AMRX - Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental …

Key Statistics

Market Cap $7B
P/E Ratio 41.96

This AMRX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track AMRX's price movements with trendlines, gamma walls, and key support/resistance levels.